Innate Immunity
Products Related to Innate Immunity(566)
- GC12288GSK-J1 sodium saltCAS: 1797832-71-3Purity: >98%
A neuropeptide with diverse biological activities
- GC18313BAR501 ImpurityCAS: 1632118-70-7Purity: >98%
BAR501 impurity is an impurity found in the preparation of BAR501 that acts as an agonist of the G protein-coupled bile acid-activated receptor (GP-BAR1).
- GC18325Ferrichrome (iron-free)CAS: 34787-28-5Purity: >98.00%
Ferrichrome (iron-free) is a ferric ionophore for Ustilago sphaerogena , which can serve as a source of iron for the enzyme ferrochelatase.
- GC18517DiapocyninCAS: 29799-22-2Purity: >98%
Diapocynin is the dimeric form of the NADPH oxidase inhibitor apocynin that has anti-inflammatory and antioxidant activities.
- GC18522Phosphatidylserines (sodium salt)CAS: 383908-63-2Purity: >95.00%
Phosphatidylserine is a naturally occurring phospholipid that comprises 2-10% of total phospholipids in mammals and is enriched in the central nervous system, particularly the retina.
- GC18552Lipoxin A4CAS: 89663-86-5Purity: >95.00%
Un ácido graso trihidroxilado que contiene un tetraeno conjugado.
- GC18572Concanavalin ACAS: 11028-71-0
Concanavalin A pertenece a los concanamicinas, una familia de antibióticos macrólidos aislados de Streptomyces diastatochromogenes, que son inhibidores altamente activos y selectivos de la vacuolar proton-ATPasa (v-[H[+]]ATPasa).
- GC18602p38 MAPK Inhibitor IVCAS: 1638-41-1Purity: >98.00%
p38 MAPK Inhibitor IV es un p38α altamente especÍfico competitivo con ATP; inhibidor de MAPK con IC50 de 0,13 y 0,55 μ M para p38α y p38β MAPK, respectivamente.
- GC18612MMP-9/MMP-13 Inhibitor ICAS: 204140-01-2Purity: >98%
MMP-9/MMP-13 inhibitor I is a cell-permeable inhibitor of matrix metalloproteinases (MMPs) that most potently inhibits MMP-9 and MMP-13 (IC50s = 0.9 nM for both).
- GC1863711β-Prostaglandin F2αCAS: 38432-87-0Purity: >98.00%
11β-Prostaglandin F2α (11β-PGF2α) is the primary plasma metabolite of PGD2 in vivo.
- GC18680Lipoxin A4 methyl esterCAS: 97643-35-1Purity: >95.00%
Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4.
- GC18681Lipoxin B4CAS: 98049-69-5Purity: >95.00%
Lipoxin B4 (LXB4) is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15(S)-HpETE by human leukocytes.
- GC18773(Rac)-BenpyrineCAS: 1333714-43-4Purity: >99.00%
La (Rac)-benpirina, un racemato de la benpirina, es un inhibidor potente y activo por vía oral del TNF-α.
- GC18835Leukotriene A4 methyl esterCAS: 73466-12-3Purity: >97.00%
Leukotriene A4 (LTA4) is synthesized in mast cells, eosinophils, and neutrophils from arachidonic acid by 5-lipoxygenase (5-LO), which exhibits both lipoxygenase and LTA4 synthase activities.
- GC18856CAY10526CAS: 938069-71-7Purity: >98.00%
CAY10526 es un inhibidor especÍfico de la PGE2 sintasa-1 microsomal (mPGES1). CAY10526 inhibe la producciÓn de PGE2 a través de la modulaciÓn selectiva de la expresiÓn de mPGES1 pero no afecta a la COX-2. CAY10526 suprime significativamente el crecimiento tumoral y aumenta la apoptosis en xenoinjertos de melanoma. CAY10526 reduce los niveles de proteÍna BCL-2 y BCL-XL (antiapoptÓticos) y aumenta los niveles de BAX y BAK (proapoptÓticos), asÍ como los niveles de caspasa 3 escindida. CAY10526 inhibe la viabilidad celular (IC50<5 μM) en tres lÍneas celulares de melanoma que expresan mPGES1.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GA20418 | 4-Hydroxy-hippuric acid | 2482-25-9 | >98.00% | |
Polyphenol metabolite. | ||||
| GC10929 | Mastoparan X | 72093-22-2 | >98% | |
G protein activator peptide | ||||
| GC12288 | GSK-J1 sodium salt | 1797832-71-3 | >98% | |
A neuropeptide with diverse biological activities | ||||
| GC18313 | BAR501 Impurity | 1632118-70-7 | >98% | |
BAR501 impurity is an impurity found in the preparation of BAR501 that acts as an agonist of the G protein-coupled bile acid-activated receptor (GP-BAR1). | ||||
| GC18325 | Ferrichrome (iron-free) | 34787-28-5 | >98.00% | |
Ferrichrome (iron-free) is a ferric ionophore for Ustilago sphaerogena , which can serve as a source of iron for the enzyme ferrochelatase. | ||||
| GC18453 | Sulochrin | 519-57-3 | >98.00% | |
Sulochrina es un metabolito fúngico producido por A. | ||||
| GC18478 | MPLA | 1246298-63-4 | - | |
| GC18487 | BC-1215 | 1507370-20-8 | >99.50% | |
BC-1215 es un inhibidor de la proteÍna 3 de la caja F (Fbxo3). | ||||
| GC18517 | Diapocynin | 29799-22-2 | >98% | |
Diapocynin is the dimeric form of the NADPH oxidase inhibitor apocynin that has anti-inflammatory and antioxidant activities. | ||||
| GC18522 | Phosphatidylserines (sodium salt) | 383908-63-2 | >95.00% | |
Phosphatidylserine is a naturally occurring phospholipid that comprises 2-10% of total phospholipids in mammals and is enriched in the central nervous system, particularly the retina. | ||||
| GC18552 | Lipoxin A4 | 89663-86-5 | >95.00% | |
Un ácido graso trihidroxilado que contiene un tetraeno conjugado. | ||||
| GC18572 | Concanavalin A | 11028-71-0 | - | |
Concanavalin A pertenece a los concanamicinas, una familia de antibióticos macrólidos aislados de Streptomyces diastatochromogenes, que son inhibidores altamente activos y selectivos de la vacuolar proton-ATPasa (v-[H[+]]ATPasa). | ||||
| GC18602 | p38 MAPK Inhibitor IV | 1638-41-1 | >98.00% | |
p38 MAPK Inhibitor IV es un p38α altamente especÍfico competitivo con ATP; inhibidor de MAPK con IC50 de 0,13 y 0,55 μ M para p38α y p38β MAPK, respectivamente. | ||||
| GC18612 | MMP-9/MMP-13 Inhibitor I | 204140-01-2 | >98% | |
MMP-9/MMP-13 inhibitor I is a cell-permeable inhibitor of matrix metalloproteinases (MMPs) that most potently inhibits MMP-9 and MMP-13 (IC50s = 0.9 nM for both). | ||||
| GC18637 | 11β-Prostaglandin F2α | 38432-87-0 | >98.00% | |
11β-Prostaglandin F2α (11β-PGF2α) is the primary plasma metabolite of PGD2 in vivo. | ||||
| GC18680 | Lipoxin A4 methyl ester | 97643-35-1 | >95.00% | |
Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4. | ||||
| GC18681 | Lipoxin B4 | 98049-69-5 | >95.00% | |
Lipoxin B4 (LXB4) is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15(S)-HpETE by human leukocytes. | ||||
| GC18773 | (Rac)-Benpyrine | 1333714-43-4 | >99.00% | |
La (Rac)-benpirina, un racemato de la benpirina, es un inhibidor potente y activo por vía oral del TNF-α. | ||||
| GC18782 | CAY10657 | 494772-86-0 | >98% | |
The NF-κB/Rel family of transcription factors induce and coordinate the expression of pro-inflammatory genes including cytokines, chemokines, interferons, MHC proteins, growth factors, and cell adhesion molecules. | ||||
| GC18821 | SGA360 | 680611-86-3 | >98% | |
SGA360 suprime la seÑalizaciÓn inflamatoria de SAA1 de una manera dependiente de AHR a través de un mecanismo que no requiere la uniÓn de AHR a su elemento de respuesta afÍn (antagonista parcial) . | ||||
| GC18835 | Leukotriene A4 methyl ester | 73466-12-3 | >97.00% | |
Leukotriene A4 (LTA4) is synthesized in mast cells, eosinophils, and neutrophils from arachidonic acid by 5-lipoxygenase (5-LO), which exhibits both lipoxygenase and LTA4 synthase activities. | ||||
| GC18856 | CAY10526 | 938069-71-7 | >98.00% | |
CAY10526 es un inhibidor especÍfico de la PGE2 sintasa-1 microsomal (mPGES1). CAY10526 inhibe la producciÓn de PGE2 a través de la modulaciÓn selectiva de la expresiÓn de mPGES1 pero no afecta a la COX-2. CAY10526 suprime significativamente el crecimiento tumoral y aumenta la apoptosis en xenoinjertos de melanoma. CAY10526 reduce los niveles de proteÍna BCL-2 y BCL-XL (antiapoptÓticos) y aumenta los niveles de BAX y BAK (proapoptÓticos), asÍ como los niveles de caspasa 3 escindida. CAY10526 inhibe la viabilidad celular (IC50<5 μM) en tres lÍneas celulares de melanoma que expresan mPGES1. | ||||
| GC18874 | Prostaglandin F2α serinol amide | 1135226-99-1 | - | |
A stable analog of PGF 2α 2glyceryl ester | ||||
| GC18877 | CAY10606 | 1159576-98-3 | >98% | |
5-Lipoxygenase (5-LO) initiates the synthesis of leukotrienes (LTs) from arachidonic acid, primarily in certain leukocyte populations. | ||||
